S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
NASDAQ:CGC

Canopy Growth Stock Forecast, Price & News

$7.64
-0.14 (-1.80%)
(As of 01/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$7.61
$8.01
50-Day Range
$7.64
$15.27
52-Week Range
$7.61
$56.50
Volume
5.85 million shs
Average Volume
6.70 million shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.96
30 days | 90 days | 365 days | Advanced Chart
Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.


Canopy Growth logo

About Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CGC
Fax
N/A
Employees
3,259
Year Founded
N/A

Sales & Book Value

Annual Sales
$414.03 million
Book Value
$6.90 per share

Profitability

Net Income
$-1.32 billion
Net Margins
-201.25%
Pretax Margin
-173.09%

Debt

Price-To-Earnings

Miscellaneous

Free Float
393,321,000
Market Cap
$3.01 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/05/2021
Today
1/20/2022
Next Earnings (Estimated)
2/08/2022
Fiscal Year End
3/31/2022

MarketRank

Overall MarketRank

1.17 out of 5 stars

Medical Sector

1215th out of 1,415 stocks

Medicinals & Botanicals Industry

15th out of 19 stocks

Analyst Opinion: 3.9Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Canopy Growth (NASDAQ:CGC) Frequently Asked Questions

Is Canopy Growth a buy right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are currently 6 sell ratings, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view top-rated stocks.

How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CGC shares have decreased by 42.8% and is now trading at $7.64.
View which stocks have been most impacted by COVID-19
.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for Canopy Growth
.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) released its quarterly earnings data on Friday, November, 5th. The company reported ($0.02) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.16) by $0.14. The company earned $145.70 million during the quarter, compared to the consensus estimate of $145.63 million. Canopy Growth had a negative trailing twelve-month return on equity of 24.66% and a negative net margin of 201.25%. The business's quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 earnings per share.
View Canopy Growth's earnings history
.

What price target have analysts set for CGC?

16 Wall Street analysts have issued twelve-month target prices for Canopy Growth's stock. Their forecasts range from $7.00 to $55.00. On average, they anticipate Canopy Growth's share price to reach $20.36 in the next twelve months. This suggests a possible upside of 166.5% from the stock's current price.
View analysts' price targets for Canopy Growth
or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • David Eric Klein, Chief Executive Officer & Non-Independent Director
  • Andrew MacCorquodale, Chief Operations Officer
  • Judy Hong, Chief Financial Officer & VP-Investor Relations
  • Ru Wadasinghe, Chief Information Officer
  • Peter Popplewell, Chief Technology Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Cutler Group LP (0.00%), Chiron Capital Management LLC (0.02%), Valeo Financial Advisors LLC (0.01%), Wedbush Securities Inc. (0.01%), NuWave Investment Management LLC (0.01%) and Spire Wealth Management (0.00%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth
.

Which institutional investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Valeo Financial Advisors LLC, Chiron Capital Management LLC, Wedbush Securities Inc., Onyx Bridge Wealth Group LLC, Investors Financial Group LLC, IFP Advisors Inc, and Patriot Financial Group Insurance Agency LLC.
View insider buying and selling activity for Canopy Growth
or view top insider-selling stocks.

Which institutional investors are buying Canopy Growth stock?

CGC stock was purchased by a variety of institutional investors in the last quarter, including Cutler Group LP, Integrated Investment Consultants LLC, NuWave Investment Management LLC, Signature Wealth Management Partners LLC, Spire Wealth Management, and Accel Wealth Management.
View insider buying and selling activity for Canopy Growth
or or view top insider-buying stocks.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $7.64.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of $3.01 billion and generates $414.03 million in revenue each year. The company earns $-1.32 billion in net income (profit) each year or ($2.66) on an earnings per share basis.

How many employees does Canopy Growth have?

Canopy Growth employs 3,259 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

Where are Canopy Growth's headquarters?

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at (855) 558-9333 or via email at [email protected].


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.